Frontiers in Endocrinology | Cancer Endocrinology

Original Research

Accepted on 30 May 2025

Epidemiology and Clinical Outcomes of Clinically Suspected Multiple Endocrine Neoplasia Type 1 in South Korea: a Nationwide Cohort Study

in Cancer Endocrinology

Kyoung Jin Kim
Min Heui Yu
Yoon-a Hwang
Shinje Moon
Namki Hong
Yumie Rhee

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1562282

Systematic Review

Accepted on 30 May 2025

Correlations between circulating adipokines and hepatocellular carcinoma (HCC): A systematic review and meta-analysis

in Cancer Endocrinology

Yani Ke
Yuyan Pan
Xueru Huang
Xing Bai
Xiaojuan Liu
Mingsi Zhang
Guangji Zhang
Tao Jiang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1548924

Original Research

Published on 29 May 2025

Incorporation of clinical features into a multivariate logistic regression model for the differential diagnosis of benign and malignant TI-RADS 4 thyroid nodules

in Cancer Endocrinology

Jun Hu
Xian Du
Yongbin Jiang
Yunle Wang
Lijuan Yang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1550034

235 views

Original Research

Published on 29 May 2025

The role of bile acid metabolism-related genes in prognosis assessment of hepatocellular carcinoma and identification of NPC1 as a biomarker

in Cancer Endocrinology

Maosen Xu
Yu Zhang
Yan Tie
Yiqiao Luo
Yang Wang
Ziqi Zhang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1588529

214 views

Review

Published on 29 May 2025

A review of adipose-derived mesenchymal stem cells‘ impacts and challenges: metabolic regulation, tumor modulation, immunomodulation, regenerative medicine and genetic engineering therapies

in Cancer Endocrinology

Lihong Wang
Xiaorui Jiang
Fen Zhao
Ping Duan
Zhengguang Li
Yiqiao Luo

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1606847

241 views

Original Research

Accepted on 28 May 2025

The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy

in Cancer Endocrinology

Aviral Singh
Sebastian Sanduleanu
Harshad Kulkarni
Thomas Langbein
Philippe Lambin
Richard P Baum

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1514792

Original Research

Published on 27 May 2025

Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre

in Cancer Endocrinology

Clotilde Sparano
Letizia Canu
Giuliano Perigli
Roberto Santoro
Silvia Pradella
Giulia Grazzini
Monica Mangoni
Gabriele Simontacchi
Benedetta Fibbi
Vania Vezzosi

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1513893

294 views

Original Research

Published on 27 May 2025

Identification and validation of prognostic genes associated with T-cell exhaustion and macrophage polarization in breast cancer

in Cancer Endocrinology

Fengqiang Cui
Changjiao Yan
Jiang Wu
Yuqing Yang
Jixin Yang
Jialing Luo
Nanlin Li

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1556496

248 views

Original Research

Accepted on 26 May 2025

Construction and validation of a predictive model for lymph node metastasis in patients with papillary thyroid carcinoma

in Cancer Endocrinology

Yan Hong Hao
Yanjng Zhang
Yuan Su
Li-ping Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1551108

Original Research

Published on 23 May 2025

Single-cell and transcriptomic analyses reveal the role of PCDH17 in the non-inflammatory tumor microenvironment of pancreatic cancer

in Cancer Endocrinology

Yong Sun
Hong Wan
Jie Xiong
Kun Cao
Dashuai Yang
Jun Huang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1559909

457 views

Review

Published on 23 May 2025

Modulation of lipid metabolism by exercise: exploring its potential as a therapeutic target in cancer endocrinology

in Cancer Endocrinology

Haodong Liu
Tong Yang
Seongbeom Choi

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1580559

400 views

Original Research

Accepted on 22 May 2025

DEPDC1 facilitated malignant phenotypes and disease progression of liposarcoma by modulating KIF20A

in Cancer Endocrinology

Mingwei Yu
Huishan Zhao
Yujie Sun

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1591390

Original Research

Published on 21 May 2025

A real-world pharmacovigilance assessment and literature review of lymphoma development in lipodystrophy

in Cancer Endocrinology

Rebecca J. Brown
David Araujo-Vilar
Kelly J. Walkovich
Alexandru Barbarosie
David A. Magee
Baris Akinci
Elif A. Oral

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1582715

526 views

Original Research

Accepted on 20 May 2025

Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on future endometrial cancer risk and the mediating role of body mass index: a cross-sectional study

in Cancer Endocrinology

Yixiao Wang
Penglin Liu
Wenzhi Kong
Chunyu Xu
Yuning Geng
Jinwei Miao

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1571693

Original Research

Accepted on 20 May 2025

Mechanistic study of quercetin in the treatment of thyroid cancer with diabetes based on network pharmacology and in vitro experiments

in Cancer Endocrinology

Siyu Liu
Wenjing Chen
Yujie Cai
Xiao Yuan
Feng Lin
Zhipeng He

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1537799

127 views

Original Research

Accepted on 19 May 2025

Reduced sensitivity to thyroid hormones is associated with differentiated thyroid cancer in the euthyroid thyroidectomy population

in Cancer Endocrinology

Huaijin Xu
Hongzhou Liu
Xiaodong Hu
Xiaomeng Jia
Zhe Xue
Anning Wang
Shaoyang Kang
Zhaohui Lyu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1595002

106 views